Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

I.S. van Houdt; B.J.R. Sluijter; L.M. Moesbergen; W. Vos; T.D. de Gruijl; B.G. Molenkamp; A.J.M. van den Eertwegh; E. Hooijberg; P.A.M. van Leeuwen; C.J.L.M. Meijer; J.J. Oudejans

doi:https://doi.org/10.1002/ijc.23543

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

I.S. van Houdt, B.J.R. Sluijter, L.M. Moesbergen, W. Vos, T.D. de Gruijl, B.G. Molenkamp, A.J.M. van den Eertwegh, E. Hooijberg, P.A.M. van Leeuwen, C.J.L.M. Meijer, J.J. Oudejans

Research output: Contribution to journal › Article › Academic › peer-review

109 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	609-615
Journal	International journal of cancer
Volume	123
Issue number	3
DOIs	https://doi.org/10.1002/ijc.23543
Publication status	Published - 2008

Access to Document

https://doi.org/10.1002/ijc.23543

Cite this

van Houdt, I. S., Sluijter, B. J. R., Moesbergen, L. M., Vos, W., de Gruijl, T. D., Molenkamp, B. G., van den Eertwegh, A. J. M., Hooijberg, E., van Leeuwen, P. A. M., Meijer, C. J. L. M., & Oudejans, J. J. (2008). Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. International journal of cancer, 123(3), 609-615. https://doi.org/10.1002/ijc.23543

@article{207075b124e746e0a19b75b4fbecf48f,

title = "Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression",

author = "{van Houdt}, I.S. and B.J.R. Sluijter and L.M. Moesbergen and W. Vos and {de Gruijl}, T.D. and B.G. Molenkamp and {van den Eertwegh}, A.J.M. and E. Hooijberg and {van Leeuwen}, P.A.M. and C.J.L.M. Meijer and J.J. Oudejans",

year = "2008",

doi = "https://doi.org/10.1002/ijc.23543",

language = "Undefined/Unknown",

volume = "123",

pages = "609--615",

journal = "International journal of cancer",

issn = "0020-7136",

publisher = "International Union Against Cancer",

number = "3",

}

van Houdt, IS, Sluijter, BJR, Moesbergen, LM, Vos, W , de Gruijl, TD, Molenkamp, BG, van den Eertwegh, AJM, Hooijberg, E, van Leeuwen, PAM, Meijer, CJLM & Oudejans, JJ 2008, 'Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression', International journal of cancer, vol. 123, no. 3, pp. 609-615. https://doi.org/10.1002/ijc.23543

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. / van Houdt, I.S.; Sluijter, B.J.R.; Moesbergen, L.M. et al.
In: International journal of cancer, Vol. 123, No. 3, 2008, p. 609-615.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

AU - van Houdt, I.S.

AU - Sluijter, B.J.R.

AU - Moesbergen, L.M.

AU - Vos, W.

AU - de Gruijl, T.D.

AU - Molenkamp, B.G.

AU - van den Eertwegh, A.J.M.

AU - Hooijberg, E.

AU - van Leeuwen, P.A.M.

AU - Meijer, C.J.L.M.

AU - Oudejans, J.J.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1002/ijc.23543

DO - https://doi.org/10.1002/ijc.23543

M3 - Article

C2 - 18498132

SN - 0020-7136

VL - 123

SP - 609

EP - 615

JO - International journal of cancer

JF - International journal of cancer

IS - 3

ER -